AMY MCGUIRE to Risk Assessment
This is a "connection" page, showing publications AMY MCGUIRE has written about Risk Assessment.
Connection Strength
0.401
-
Who's on third? Regulation of third-party genetic interpretation services. Genet Med. 2020 01; 22(1):4-11.
Score: 0.086
-
Why information alone is not enough: behavioral economics and the future of genomic medicine. Ann Intern Med. 2014 Oct 21; 161(8):605-6.
Score: 0.061
-
Adult genetic risk screening. Annu Rev Med. 2014; 65:1-17.
Score: 0.057
-
The legal risks of returning results of genomics research. Genet Med. 2012 Apr; 14(4):473-7.
Score: 0.051
-
Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics. 2012; 15(2):106-14.
Score: 0.051
-
Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project. Pediatrics. 2019 01; 143(Suppl 1):S6-S13.
Score: 0.021
-
Challenging the Current Recommendations for Carrier Testing in Children. Pediatrics. 2019 01; 143(Suppl 1):S27-S32.
Score: 0.021
-
The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225.
Score: 0.020
-
The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. Ann Intern Med. 2017 08 01; 167(3):159-169.
Score: 0.018
-
Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Genet. 2010 02; 11(2):161-5.
Score: 0.011
-
Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction. Eur Heart J. 1997 Sep; 18(9):1411-5.
Score: 0.005